Our esketamine spravato treatment provides a clinically advanced solution for individuals with treatment-resistant depression. As a leading Spravato facility, we offer FDA-approved Spravato therapy in a structured, medically supervised environment. This innovative treatment is designed to help patients who have not responded to traditional medications achieve faster symptom relief and improved overall mental health outcomes.
Schedule a Consultation Today
Spravato is a prescription nasal spray containing esketamine that is FDA-approved for the treatment of treatment-resistant depression. Spravato is an FDA-approved prescription nasal spray used alongside an oral antidepressant to treat treatment-resistant depression (TRD) and certain cases of major depressive disorder with suicidal thoughts or behaviors.
Unlike traditional antidepressants, which primarily affect serotonin pathways, Spravato targets the brain’s glutamate system, which plays a critical role in mood regulation and neural connectivity.
At Avatar Behavioral Health, Spravato treatment is delivered in a certified clinical setting under the FDA Risk Evaluation and Mitigation Strategy (REMS) program, ensuring patient safety and proper monitoring.
Spravato therapy may be recommended for individuals who:
Our clinicians conduct a comprehensive psychiatric evaluation to determine whether Spravato therapy is appropriate for each patient.
A licensed clinician evaluates your symptoms, treatment history, and overall mental health to determine eligibility for Spravato therapy.
Spravato is administered as a nasal spray under clinical supervision at our treatment center.
Patients remain at the clinic for approximately two hours of observation following treatment to ensure safety.
Spravato therapy is typically delivered on a structured schedule as part of a broader mental health treatment plan.
Spravato therapy may be recommended for individuals experiencing:
Our clinical team works closely with each patient to develop a personalized treatment strategy.
Traditional antidepressants typically target serotonin and dopamine pathways. Spravato works differently by influencing the glutamate system, which is involved in synaptic communication in the brain. This alternative mechanism may help individuals who have not responded to conventional treatments.
Choosing the right Spravato treatment center in New Jersey is important for both safety and treatment effectiveness.
Avatar Behavioral Health provides:
Our goal is to provide advanced mental health treatment options while prioritizing patient safety and compassionate care.
During an Spravato treatment appointment:
Because Spravato may temporarily affect alertness, patients must arrange transportation following treatment.
Many insurance providers cover Spravato therapy for treatment-resistant depression when medical criteria are met.
Avatar Behavioral Health is committed to providing evidence-based mental health care in New Jersey through personalized treatment and compassionate support. Patients benefit from:
